Application number | Title of the application | Filing Date | Status |
---|
09/491780 | High affinity ligands for nociceptin receptor ORL-1 | Jan 25, 2000 | Abandoned |
Array
(
[id] => 4238288
[patent_doc_number] => 06166053
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Substituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasia'
[patent_app_type] => 1
[patent_app_number] => 9/490269
[patent_app_country] => US
[patent_app_date] => 2000-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13905
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/166/06166053.pdf
[firstpage_image] =>[orig_patent_app_number] => 490269
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/490269 | Substituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasia | Jan 23, 2000 | Issued |
Array
(
[id] => 4273367
[patent_doc_number] => 06323235
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Benzene-condensed heterocyclic derivatives and their uses'
[patent_app_type] => 1
[patent_app_number] => 9/482279
[patent_app_country] => US
[patent_app_date] => 2000-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63866
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 682
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323235.pdf
[firstpage_image] =>[orig_patent_app_number] => 482279
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/482279 | Benzene-condensed heterocyclic derivatives and their uses | Jan 12, 2000 | Issued |
09/481197 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | Jan 10, 2000 | Abandoned |
Array
(
[id] => 7645577
[patent_doc_number] => 06472392
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Triazole compounds and the use thereof as dopamine-D3 -ligands'
[patent_app_type] => B1
[patent_app_number] => 09/446520
[patent_app_country] => US
[patent_app_date] => 1999-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15123
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472392.pdf
[firstpage_image] =>[orig_patent_app_number] => 09446520
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446520 | Triazole compounds and the use thereof as dopamine-D3 -ligands | Dec 27, 1999 | Issued |
Array
(
[id] => 910436
[patent_doc_number] => 07329670
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-02-12
[patent_title] => 'Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas'
[patent_app_type] => utility
[patent_app_number] => 09/472232
[patent_app_country] => US
[patent_app_date] => 1999-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11394
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329670.pdf
[firstpage_image] =>[orig_patent_app_number] => 09472232
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/472232 | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas | Dec 26, 1999 | Issued |
Array
(
[id] => 4312041
[patent_doc_number] => 06316440
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Reduced dipeptide analogues as calcium channel antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/381983
[patent_app_country] => US
[patent_app_date] => 1999-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8705
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316440.pdf
[firstpage_image] =>[orig_patent_app_number] => 381983
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381983 | Reduced dipeptide analogues as calcium channel antagonists | Dec 26, 1999 | Issued |
Array
(
[id] => 4383088
[patent_doc_number] => 06294547
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-25
[patent_title] => 'Naphthyridine deratives or salts thereof'
[patent_app_type] => 1
[patent_app_number] => 9/446452
[patent_app_country] => US
[patent_app_date] => 1999-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17729
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/294/06294547.pdf
[firstpage_image] =>[orig_patent_app_number] => 446452
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446452 | Naphthyridine deratives or salts thereof | Dec 20, 1999 | Issued |
Array
(
[id] => 1501030
[patent_doc_number] => 06486180
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-26
[patent_title] => 'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'
[patent_app_type] => B1
[patent_app_number] => 09/465948
[patent_app_country] => US
[patent_app_date] => 1999-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65152
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 4508
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/486/06486180.pdf
[firstpage_image] =>[orig_patent_app_number] => 09465948
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/465948 | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | Dec 16, 1999 | Issued |
09/465286 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Dec 16, 1999 | Abandoned |
Array
(
[id] => 1419999
[patent_doc_number] => 06514967
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same'
[patent_app_type] => B1
[patent_app_number] => 09/424208
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 14433
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514967.pdf
[firstpage_image] =>[orig_patent_app_number] => 09424208
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/424208 | Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same | Dec 15, 1999 | Issued |
09/464037 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | Dec 14, 1999 | Abandoned |
Array
(
[id] => 1528370
[patent_doc_number] => 06479495
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Aminoalkylphenol derivatives and related compounds'
[patent_app_type] => B1
[patent_app_number] => 09/459046
[patent_app_country] => US
[patent_app_date] => 1999-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33215
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 297
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479495.pdf
[firstpage_image] =>[orig_patent_app_number] => 09459046
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/459046 | Aminoalkylphenol derivatives and related compounds | Dec 9, 1999 | Issued |
Array
(
[id] => 4360415
[patent_doc_number] => 06255315
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Alpha 1a adrenergic receptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/458169
[patent_app_country] => US
[patent_app_date] => 1999-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38414
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255315.pdf
[firstpage_image] =>[orig_patent_app_number] => 458169
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/458169 | Alpha 1a adrenergic receptor antagonists | Dec 8, 1999 | Issued |
Array
(
[id] => 1514762
[patent_doc_number] => 06420354
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Sodium channel drugs and uses'
[patent_app_type] => B1
[patent_app_number] => 09/458107
[patent_app_country] => US
[patent_app_date] => 1999-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 31
[patent_no_of_words] => 59172
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420354.pdf
[firstpage_image] =>[orig_patent_app_number] => 09458107
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/458107 | Sodium channel drugs and uses | Dec 7, 1999 | Issued |
Array
(
[id] => 4396960
[patent_doc_number] => 06297249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-02
[patent_title] => 'Integrin receptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/453847
[patent_app_country] => US
[patent_app_date] => 1999-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49505
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 368
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/297/06297249.pdf
[firstpage_image] =>[orig_patent_app_number] => 453847
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453847 | Integrin receptor antagonists | Dec 1, 1999 | Issued |
Array
(
[id] => 4421826
[patent_doc_number] => 06225318
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => '4-aminoquinazolone derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/449855
[patent_app_country] => US
[patent_app_date] => 1999-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13304
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/225/06225318.pdf
[firstpage_image] =>[orig_patent_app_number] => 449855
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/449855 | 4-aminoquinazolone derivatives | Nov 25, 1999 | Issued |
Array
(
[id] => 1404555
[patent_doc_number] => 06534516
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-18
[patent_title] => 'Androgen receptor modulator compounds and methods'
[patent_app_type] => B1
[patent_app_number] => 09/448992
[patent_app_country] => US
[patent_app_date] => 1999-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26440
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534516.pdf
[firstpage_image] =>[orig_patent_app_number] => 09448992
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/448992 | Androgen receptor modulator compounds and methods | Nov 23, 1999 | Issued |
Array
(
[id] => 4410267
[patent_doc_number] => 06228848
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities'
[patent_app_type] => 1
[patent_app_number] => 9/447082
[patent_app_country] => US
[patent_app_date] => 1999-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 30
[patent_no_of_words] => 67256
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 581
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228848.pdf
[firstpage_image] =>[orig_patent_app_number] => 447082
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/447082 | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities | Nov 21, 1999 | Issued |
Array
(
[id] => 4358328
[patent_doc_number] => 06218544
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Heterocyclic esters and amides'
[patent_app_type] => 1
[patent_app_number] => 9/442628
[patent_app_country] => US
[patent_app_date] => 1999-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 6550
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218544.pdf
[firstpage_image] =>[orig_patent_app_number] => 442628
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/442628 | Heterocyclic esters and amides | Nov 17, 1999 | Issued |